CHRNA9 and triple-negative breast carcinoma: Furthermore, a clinical investigation of HER2+ breast tissues revealed a strong protein interaction between CHRNA9 and ERBB2 compared to that in triple-negative breast cancer (TNBC) breast tissues (Fig. 6c).